Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O0LC
|
|||
| Former ID |
DNCL002658
|
|||
| Drug Name |
MER-101
|
|||
| Synonyms |
Zoledronic acid oral
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Bone metastases [ICD-11: 2D50; ICD-10: C79.5; ICD-9: 198.5] | Phase 2 | [1] | |
| Company |
Merrion Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H12N2O8P2
|
|||
| Canonical SMILES |
C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O
|
|||
| InChI |
1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
|
|||
| InChIKey |
FUXFIVRTGHOMSO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 165800-06-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
7849030, 10239697, 12014262, 16755669, 29302137, 50064535, 57339777, 79050974, 92722605, 99452951, 104413779, 118043414, 126434868, 126618116, 126662329, 131295780, 132048653, 135075889, 162177459, 162800487, 163813146, 175268945, 175612211, 175612525, 176253509, 187072269, 188932234, 210274976, 210280614, 223383654, 223661117, 226759277, 249822643, 250183737, 250220800, 251916630, 251917899, 252056862, 252091204, 252314576, 252377776, 252433173
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00636740) Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.